1.646.889.1200|info@lifescipublicrelations.com

Modifying the Immune Response in Celiac

//Modifying the Immune Response in Celiac

Modifying the Immune Response in Celiac

Leslie Williams, CEO of ImmusanT, discusses the company’s research for developing a disease-modifying therapeutic for patients with celiac disease.

By | 2019-01-17T16:41:49-04:00 January 1st, 2019|News|Comments Off on Modifying the Immune Response in Celiac

About the Author:

Related Posts

LifeSci Public Relations

LifeSci Public Relations LLC is a corporate communications and public relations firm helping clients engage their corporate audiences and achieve their business objectives via a broad array of traditional, social and digital media tools.